Keyphrases
Vascular Endothelial Growth Factor
100%
Bioactivity
100%
Tumor Progression
100%
B Domain
100%
Neuropilin-2
100%
Inhibit Tumor
100%
Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
30%
Neuropilin-1 (NRP-1)
23%
Avastin
23%
Angiogenesis
15%
Tumor Growth
15%
Monoclonal Antibody
7%
Three-dimensional (3D)
7%
Tumor
7%
Complex Formation
7%
Induced Activation
7%
Cell Survival
7%
Neuropilin
7%
Co-receptor
7%
125I
7%
Mutagenesis
7%
Factor Interaction
7%
Embryoid Body
7%
Bevacizumab
7%
Growth Factor Binding
7%
Melanocytic Tumor
7%
Human Melanoma Cells
7%
Human Melanoma
7%
Biochemistry, Genetics and Molecular Biology
NRP2
100%
Tumor Progression
100%
Vascular Endothelial Growth Factor
100%
Neuropilin
100%
Biological Activity
100%
Kinase Insert Domain Receptor
33%
Bevacizumab
33%
Angiogenesis
16%
Mutagenesis
8%
Complex Formation
8%
Cell Survival
8%
Mediator
8%
Embryoid Body
8%
Sprouting
8%
Monoclonal Antibody
8%
Iodine-125
8%
Protein Kinase B
8%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Growth
100%
Neuropilin 2
100%
Vasculotropin
100%
Vasculotropin Receptor 2
33%
Bevacizumab
33%
Melanoma
16%
Mutagenesis
8%
Iodine-125
8%
Malignant Neoplasm
8%
Monoclonal Antibody
8%
Neoplasm
8%
Protein Kinase B
8%
Neuropilin
8%
Immunology and Microbiology
Vasculotropin
100%
Biological Activity
100%
Bevacizumab
33%
Kinase Insert Domain Receptor
33%
Angiogenesis
16%
Sprouting
8%
Complex Formation
8%
Monoclonal Antibody
8%
Cell Survival
8%
Mediator
8%
Melanoma Cell
8%
Embryoid Body
8%
Mutagenesis
8%
Iodine-125
8%